Jane Street Group LLC Takes Position in Rockwell Medical, Inc. (NASDAQ:RMTI)

Jane Street Group LLC acquired a new stake in Rockwell Medical, Inc. (NASDAQ:RMTI) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 134,390 shares of the company’s stock, valued at approximately $534,000. Jane Street Group LLC owned about 0.42% of Rockwell Medical at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Armistice Capital LLC boosted its holdings in shares of Rockwell Medical by 22.5% in the 2nd quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock valued at $5,670,000 after acquiring an additional 592,000 shares during the last quarter. Walleye Capital LLC purchased a new stake in shares of Rockwell Medical in the 3rd quarter valued at $435,000. Renaissance Technologies LLC boosted its holdings in shares of Rockwell Medical by 877.1% in the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after acquiring an additional 92,189 shares during the last quarter. State Street Corp boosted its holdings in shares of Rockwell Medical by 21.5% in the 3rd quarter. State Street Corp now owns 95,004 shares of the company’s stock valued at $377,000 after acquiring an additional 16,800 shares during the last quarter. Finally, Corsair Capital Management L.P. purchased a new stake in shares of Rockwell Medical in the 3rd quarter valued at $298,000. 23.31% of the stock is owned by hedge funds and other institutional investors.

Rockwell Medical Stock Performance

Shares of NASDAQ RMTI opened at $2.33 on Monday. The company’s fifty day moving average price is $2.61 and its 200 day moving average price is $2.72. Rockwell Medical, Inc. has a 1 year low of $1.16 and a 1 year high of $5.15. The company has a market capitalization of $75.30 million, a PE ratio of -46.60 and a beta of 1.38. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.41.

Analyst Upgrades and Downgrades

Several research firms have recently commented on RMTI. Rodman & Renshaw assumed coverage on shares of Rockwell Medical in a report on Thursday, November 14th. They issued a “buy” rating and a $5.00 price objective on the stock. RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th. StockNews.com downgraded shares of Rockwell Medical from a “buy” rating to a “hold” rating in a report on Friday, December 20th. Finally, HC Wainwright reissued a “buy” rating and set a $7.00 price target on shares of Rockwell Medical in a report on Monday, December 23rd.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.